ArticleMarine drugs2017

Tuberatolide B Suppresses Cancer Progression by Promoting ROS-Mediated Inhibition of STAT3 Signaling.

Youn Kyung Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.